OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
DNA Cell Cycle Analysis by Flow Cytometry
IMMray, PanCan-d Test for Early Detection of Pancreatic Cancer
Methylation Cancer Marker Detection in Cell-free Circulating Tumor DNA (Northstar Select and Response™)
MSH2 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
Dihydropyrimidine Dehydrogenase (DPYD) Genotyping
Minimal Residual Disease (MRD) for Early Detection of Cancer Recurrence (Signatera™, Haystack MRD™)
Cancer Antigen (CA) 19-9, Serum
Chronic liver disease
Partner and Localizer of BRCA2 (PALB2) Gene Mutation Analysis
LDS
Sign up
Log in
LDS
/
Medical Tests
/
OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
Medical Test
Additional ICD10
Access to
OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
is restricted.
Sign up now
Loading...